CIK 0001274737
- Non-accelerated filer
- Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 760-560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CFO and Corporate Secretary sold 3,667 shares at $2.30 ($8,432)
- 4 Open-market sale Chief Business Officer sold 3,667 shares
- 4 Grant or award CFO and Corporate Secretary acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 100,000 shares (grant or award)
- 4 Open-market sale Chief Business Officer sold 5,821 shares at $2.69 ($15,672)
- 4 Open-market sale CFO and Corporate Secretary sold 5,821 shares at $2.69 ($15,671)
- 4 Open-market buy President and CEO bought 90,000 shares at $2.68 ($241,200)
- 4 Grant or award President and CEO acquired 350,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,241 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 3,241 shares (to pay taxes)
Page 4 of 9 · 168 filings